Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility? - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Hepatology Année : 2019

Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?

Résumé

We have read with great interest the article by Jucaud et al. (1) reporting that de novo donor-specific HLA antibodies (dnDSA) development during immunosuppression (IS) withdrawal in liver transplantation (LT) was associated with acute rejection and prevented further attempts of IS withdrawal.

Domaines

Médecine humaine et pathologie

Amandine Michel-Avella  : Connectez-vous pour contacter le contributeur

https://hal.umontpellier.fr/hal-02563429

Soumis le : mardi 5 mai 2020-12:23:18

Dernière modification le : vendredi 9 septembre 2022-10:22:07

Fichier non déposé

Dates et versions

hal-02563429 , version 1 (05-05-2020)

Identifiants

Citer

Magdalena Meszaros, José Ursic‐bedoya, Stéphanie Faure, Georges‐philippe Pageaux. Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?. Hepatology, 2019, 69 (5), pp.2302-2303. ⟨10.1002/hep.30345⟩. ⟨hal-02563429⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

BS UNIV-MONTPELLIER
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More